Episode Details

UpNext AI for June 18, 2026: today we’re tracking a reported clash between the White House and Anthropic over jailbreak-proofing a model rerelease, a big funding signal for world models as Odyssey hits a $1.45 billion valuation with Amazon among its backers, and a new benchmark testing whether AI agents can actually make useful preclinical pharmacology decisions. We also round out the show with quick headlines on OpenAI’s pre-launch failure prediction work, an AI chemist result from OpenAI and Molecule.one, and Google’s latest AMIE medical study.

Covered in this episode:
- The White House reportedly wants Anthropic to make Fable 5’s guardrails impossible to circumvent before any rerelease
- Odyssey reaches a $1.45 billion valuation in a Series B round with Amazon among the backers
- TxBench-PP tests AI agents on realistic small-molecule preclinical pharmacology decisions
- OpenAI researchers propose a way to predict how often models may fail before launch
- OpenAI and Molecule.one say a near-autonomous AI chemist improved a challenging medicinal chemistry reaction
- Google says new Nature research shows AMIE matched primary care physicians in complex disease management

Source links:
- WIRED: https://www.wired.com/story/the-white-house-wants-anthropic-to-block-all-jailbreaks-that-may-not-be-possible/
- TechCrunch: https://techcrunch.com/2026/06/17/world-model-maker-odyssey-nabs-1-45b-valuation-backed-by-amazon-and-other-big-names/
- arXiv (TxBench-PP): https://arxiv.org/abs/2606.19245v1
- The Decoder: https://the-decoder.com/openai-researchers-want-to-predict-how-often-ai-models-will-fail-before-launch/
- OpenAI: https://openai.com/index/ai-chemist-improves-reaction
- Google: https://blog.google/innovation-and-ai/models-and-research/google-research/amie-for-disease-management-in-nature/